tirzepatide 台灣 上市 👩‍⚕️美國FDA核准但台灣尚未核准上市之藥物🟣#Zepbound® (Tirzepatide)Tirzepatide 是一種#雙重腸泌素促效劑， 可#同時活化GLP-1及葡萄糖依賴性促胰島素肽(glucose-dependent insulinotropic polypeptide, GIP)兩種受體。 🔵此藥物用於治療糖尿病的商品名為# 美食品暨藥物管理局核准禮來減肥藥Zepbound 上市| TechNews 科技新報

Weinhandl, E

Why microdose

Lab testing should be used in conjunction with guidance from a qualified healthcare provider

The formula contains no fat, no sugar, no artificial flavors, no sweeteners, no antibiotics, and no gluten

Maternal considerations: Gastrointestinal effects : nausea, vomiting, diarrhoea and reduced appetite are common with tirzepatide

Samples were processed for protein isolation using RIPA buffer (Boston Bio-product, Ashland, MA) with protease inhibitors cocktail (Cell signaling technology, Danvers, MA), quantified by Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA) and 40 g of proteins were boiled with 4 denaturing Laemmli Sample Buffer (Bio-Rad Laboratories, Hercules, CA) and loaded on 7.5% SDS-PAGE gel